ChristopherNealPrichardMD

Otolaryngic Allergy, Ped Otolaryngology (ENT), Rhinology & Paranasal Sinus Disease

Partner at Rosewood ENT

Dr. Prichard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2003 - 2007
Baylor College of MedicineInternship, Transitional Year, 2002 - 2003
Harvard Medical SchoolClass of 2002

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Fellow (FACS) American College of Surgeons

PubMed

39 citations
Concurrent Cetuximab and Bevacizumab Therapy in a Murine Orthotopic Model of Anaplastic Thyroid Carcinoma
Christopher N. Prichard, Seungwon Kim, Yasmin D. Yazici, Dao D. Doan, Samar A. Jasser, Mahitosh Mandal, Jeffrey N. Myers> ;The Laryngoscope. 2007 Apr 1
29 citations
Use of the Photonic Band Gap Fiber Assembly CO2 Laser System in Head and Neck Surgical Oncology
F. Christopher Holsinger, Christopher N. Prichard, Gil Shapira, Ori Weisberg, David Scott Torres, Charalambos Anastassiou, Einat Harel, Yoel Fink, Randal S. Weber> ;The Laryngoscope. 2006 Jul 1
62 citations
Adult Spontaneous CSF Otorrhea: Correlation with Radiographic Empty Sella:
Christopher N. Prichard, Brandon Isaacson, John S. Oghalai, Newton J. Coker, Jeffrey T. Vrabec> ;Otolaryngology--Head and Neck Surgery. 2006 May 1
76 citations
Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.
Seungwon Kim, Christopher N. Prichard, Maher N. Younes, Yasemin D. Yazici, Samar A. Jasser, B. Nebiyou Bekele, Jeffrey N. Myers> ;Clinical Cancer Research. 2006 Jan 15
Join now to see all